Birdwatch Note
2024-08-01 15:50:24 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
En Argelia la transición de género es ilegal, por lo cual no tiene sentido que Khelif lo sea. Por otro lado, anteriormente la peleadora ha sido polémica por sus altos niveles de testosterona, que puede ser normal en una mujer biológica y no indica que sea transgénero. https://outrightinternational.org/our-work/middle-east-and-north-africa/algeria https://www.google.com/amp/s/redmas.com.co/amp/deportes/Ella-es-Imane-Khelif-la-boxeadora-argelina-con-altos-niveles-de-testosterona-en-los-Juegos-Olimpicos-20240801-0010.html https://www.healthline.com/health/high-testosterone-in-women
Written by 835857C1237C1E5B8DD7EEBF2912097E6E0570134DED5F85250BED33FD0F941D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1819014250423025946
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1819037975214186778
- noteId - 1819037975214186778
- participantId -
- noteAuthorParticipantId - 835857C1237C1E5B8DD7EEBF2912097E6E0570134DED5F85250BED33FD0F941D Participant Details
- createdAtMillis - 1722527424038
- tweetId - 1819014250423025946
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- En Argelia la transición de género es ilegal, por lo cual no tiene sentido que Khelif lo sea. Por otro lado, anteriormente la peleadora ha sido polémica por sus altos niveles de testosterona, que puede ser normal en una mujer biológica y no indica que sea transgénero. https://outrightinternational.org/our-work/middle-east-and-north-africa/algeria https://www.google.com/amp/s/redmas.com.co/amp/deportes/Ella-es-Imane-Khelif-la-boxeadora-argelina-con-altos-niveles-de-testosterona-en-los-Juegos-Olimpicos-20240801-0010.html https://www.healthline.com/health/high-testosterone-in-women
Note Ratings
rated at | rated by | |
2024-08-04 15:36:53 -0500 | Rating Details | |
2024-08-03 12:36:56 -0500 | Rating Details | |
2024-08-03 01:20:20 -0500 | Rating Details | |
2024-08-02 14:11:18 -0500 | Rating Details | |
2024-08-02 13:47:00 -0500 | Rating Details | |
2024-08-02 11:37:23 -0500 | Rating Details | |
2024-08-02 11:29:43 -0500 | Rating Details | |
2024-08-02 10:39:56 -0500 | Rating Details | |
2024-08-02 07:44:14 -0500 | Rating Details | |
2024-08-02 07:18:09 -0500 | Rating Details | |
2024-08-02 06:53:47 -0500 | Rating Details | |
2024-08-02 06:35:57 -0500 | Rating Details | |
2024-08-02 02:17:03 -0500 | Rating Details | |
2024-08-02 00:34:38 -0500 | Rating Details | |
2024-08-01 23:06:47 -0500 | Rating Details | |
2024-08-01 21:48:42 -0500 | Rating Details | |
2024-08-01 21:32:49 -0500 | Rating Details | |
2024-08-01 20:33:19 -0500 | Rating Details | |
2024-08-01 20:10:22 -0500 | Rating Details | |
2024-08-01 19:02:49 -0500 | Rating Details | |
2024-08-01 18:56:13 -0500 | Rating Details | |
2024-08-01 18:17:49 -0500 | Rating Details | |
2024-08-01 17:47:28 -0500 | Rating Details | |
2024-08-01 17:44:05 -0500 | Rating Details | |
2024-08-01 17:35:15 -0500 | Rating Details | |
2024-08-01 17:11:46 -0500 | Rating Details | |
2024-08-01 16:43:24 -0500 | Rating Details | |
2024-08-01 15:45:29 -0500 | Rating Details | |
2024-08-01 15:24:30 -0500 | Rating Details | |
2024-08-01 15:21:47 -0500 | Rating Details | |
2024-08-01 15:20:46 -0500 | Rating Details | |
2024-08-01 15:11:33 -0500 | Rating Details | |
2024-08-01 14:53:47 -0500 | Rating Details | |
2024-08-01 14:40:41 -0500 | Rating Details | |
2024-08-01 14:38:26 -0500 | Rating Details | |
2024-08-01 14:18:26 -0500 | Rating Details | |
2024-08-01 14:10:51 -0500 | Rating Details | |
2024-08-01 13:50:01 -0500 | Rating Details | |
2024-08-01 13:41:15 -0500 | Rating Details | |
2024-08-01 13:40:57 -0500 | Rating Details | |
2024-08-01 13:32:49 -0500 | Rating Details | |
2024-08-01 13:07:58 -0500 | Rating Details | |
2024-08-01 13:02:03 -0500 | Rating Details | |
2024-08-01 12:59:59 -0500 | Rating Details | |
2024-08-01 12:56:59 -0500 | Rating Details | |
2024-08-01 12:55:56 -0500 | Rating Details | |
2024-08-01 12:53:14 -0500 | Rating Details | |
2024-08-01 12:52:15 -0500 | Rating Details | |
2024-08-01 12:51:51 -0500 | Rating Details | |
2024-08-01 12:44:35 -0500 | Rating Details | |
2024-08-01 12:37:32 -0500 | Rating Details | |
2024-08-01 12:15:43 -0500 | Rating Details | |
2024-08-01 12:14:27 -0500 | Rating Details | |
2024-08-01 12:11:43 -0500 | Rating Details | |
2024-08-01 12:08:38 -0500 | Rating Details | |
2024-08-01 12:06:57 -0500 | Rating Details | |
2024-08-01 11:58:27 -0500 | Rating Details | |
2024-08-01 11:53:57 -0500 | Rating Details | |
2024-08-01 11:52:13 -0500 | Rating Details | |
2024-08-01 11:49:03 -0500 | Rating Details | |
2024-08-01 11:48:27 -0500 | Rating Details | |
2024-08-01 11:47:39 -0500 | Rating Details | |
2024-08-01 11:46:49 -0500 | Rating Details | |
2024-08-01 11:46:47 -0500 | Rating Details | |
2024-08-01 11:45:54 -0500 | Rating Details | |
2024-08-01 11:42:49 -0500 | Rating Details | |
2024-08-01 11:41:33 -0500 | Rating Details | |
2024-08-01 11:41:30 -0500 | Rating Details | |
2024-08-01 11:40:32 -0500 | Rating Details | |
2024-08-01 11:39:59 -0500 | Rating Details | |
2024-08-01 11:35:20 -0500 | Rating Details | |
2024-08-01 11:34:10 -0500 | Rating Details | |
2024-08-01 11:33:11 -0500 | Rating Details | |
2024-08-01 11:28:16 -0500 | Rating Details | |
2024-08-01 11:26:33 -0500 | Rating Details | |
2024-08-01 11:25:04 -0500 | Rating Details | |
2024-08-01 11:24:40 -0500 | Rating Details | |
2024-08-01 11:22:26 -0500 | Rating Details | |
2024-08-01 11:21:46 -0500 | Rating Details | |
2024-08-01 11:20:56 -0500 | Rating Details | |
2024-08-01 11:17:46 -0500 | Rating Details | |
2024-08-01 11:11:20 -0500 | Rating Details | |
2024-08-01 11:10:21 -0500 | Rating Details | |
2024-08-01 11:09:50 -0500 | Rating Details | |
2024-08-01 11:09:39 -0500 | Rating Details | |
2024-08-01 11:09:27 -0500 | Rating Details | |
2024-08-01 11:09:13 -0500 | Rating Details | |
2024-08-01 11:08:08 -0500 | Rating Details | |
2024-08-01 11:08:04 -0500 | Rating Details | |
2024-08-01 11:07:21 -0500 | Rating Details | |
2024-08-01 11:06:56 -0500 | Rating Details | |
2024-08-01 11:06:27 -0500 | Rating Details | |
2024-08-01 11:05:48 -0500 | Rating Details | |
2024-08-01 11:04:56 -0500 | Rating Details | |
2024-08-01 11:03:07 -0500 | Rating Details | |
2024-08-01 10:58:37 -0500 | Rating Details | |
2024-08-01 10:58:27 -0500 | Rating Details | |
2024-08-01 10:57:27 -0500 | Rating Details | |
2024-08-01 10:56:49 -0500 | Rating Details | |
2024-08-01 10:56:06 -0500 | Rating Details | |
2024-08-01 10:55:05 -0500 | Rating Details | |
2024-08-01 10:54:55 -0500 | Rating Details | |
2024-08-01 10:54:27 -0500 | Rating Details | |
2024-08-01 10:53:01 -0500 | Rating Details | |
2024-08-01 10:51:53 -0500 | Rating Details | |
2024-08-01 10:51:06 -0500 | Rating Details | |
2024-08-01 10:51:01 -0500 | Rating Details | |
2024-08-01 10:50:51 -0500 | Rating Details | |
2024-08-05 15:11:09 -0500 | Rating Details | |
2024-08-04 01:40:31 -0500 | Rating Details | |
2024-08-02 03:17:15 -0500 | Rating Details | |
2024-08-01 19:40:52 -0500 | Rating Details |